APA (7th ed.) Citation

FL, C., E, D., F, G., F, P., P, B., S, G., . . . D, C. (2025). Capmatinib for the treatment of METex14 skipping non-small cell lung cancer: Retrospective analysis of real-world data from patients receiving compassionate use treatment in Italy. Clinical and experimental medicine, 26(1), 18. https://doi.org/10.1007/s10238-025-01934-2

Chicago Style (17th ed.) Citation

FL, Cecere, et al. "Capmatinib for the Treatment of METex14 Skipping Non-small Cell Lung Cancer: Retrospective Analysis of Real-world Data from Patients Receiving Compassionate Use Treatment in Italy." Clinical and Experimental Medicine 26, no. 1 (2025): 18. https://doi.org/10.1007/s10238-025-01934-2.

MLA (9th ed.) Citation

FL, Cecere, et al. "Capmatinib for the Treatment of METex14 Skipping Non-small Cell Lung Cancer: Retrospective Analysis of Real-world Data from Patients Receiving Compassionate Use Treatment in Italy." Clinical and Experimental Medicine, vol. 26, no. 1, 2025, p. 18, https://doi.org/10.1007/s10238-025-01934-2.